Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Terminated 2 Completed 2 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Tongue Neoplasms 1 Photosensitivity Disorders 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Keratosis, Actinic 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1

Interventions

Gemcitabine 6 Cisplatin 5 infigratinib 2 Platinum 2 Fluorouracil 2 1,2-diaminocyclohexaneplatinum II citrate 2 ricolinostat 1 niraparib 1 lenvatinib 1 galactomannan 1 fludarabine 1 famitinib 1 dostarlimab 1 atezolizumab 1 aldesleukin 1 Taxes 1 Standard of Care 1 Sildenafil Citrate 1 Sevoflurane 1 Photochemotherapy 1 Oxaliplatin 1 Observation 1 NVP-BKM120 1 Interviews as Topic 1 IMC-001 1 Electroporation 1 Desflurane 1 Cyclophosphamide 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cholangiocarcinoma × Photochemotherapy × Clear all

NCT00713687 2012-08-10

GemOx-PDT

Technical University of Munich

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡